Janet Liang Sells 12,475 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 12,475 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider directly owned 259,057 shares in the company, valued at $5,683,710.58. This represents a 4.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

OSCR traded up $3.04 during midday trading on Thursday, hitting $23.54. 10,532,228 shares of the company were exchanged, compared to its average volume of 7,845,401. The company’s 50 day simple moving average is $17.92 and its 200 day simple moving average is $15.93. The firm has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a price-to-earnings-growth ratio of 1.48 and a beta of 2.37. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $25.58.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. During the same period last year, the firm earned $0.92 EPS. The company’s quarterly revenue was up 52.6% on a year-over-year basis. As a group, sell-side analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Analyst Ratings Changes

OSCR has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Tuesday, April 21st. Robert W. Baird raised their target price on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. UBS Group raised their target price on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Barclays raised their target price on Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 26th. Finally, Wall Street Zen upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 9th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.22.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jones Financial Companies Lllp lifted its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in Oscar Health in the 1st quarter valued at about $30,000. Fifth Third Bancorp lifted its stake in Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares in the last quarter. Quarry LP lifted its stake in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Finally, Tsfg LLC purchased a new position in Oscar Health in the 3rd quarter valued at about $38,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.